跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 204 条关于
“DPP4”
全部
204
临床试验
172
药物
12
机构
1
资讯
19
去年
GLP-1 Receptor Agonists Show Lower Risk for MACE and VTE in Lupus and Type 2 Diabetes Patients Compared to DPP4 Inhibitors
去年
DPP4 Inhibitor Shows Promise in Rejuvenating Lung Stem Cells for Idiopathic Pulmonary Fibrosis
2年前
GLP-1 Receptor Agonists Show Survival Benefit in Cancer Patients with Type 2 Diabetes
10个月前
MetaVia's Vanoglipel Shows Dual Benefits in MASH Phase 2a Trial with Significant HbA1c Reduction and Liver Improvements
7个月前
StarkAge Therapeutics Partners with Gustave Roussy to Advance First-in-Class Senolytic ADC for Digestive Cancers
去年
Empagliflozin May Slow Diabetic Retinopathy Progression in Type 2 Diabetes
去年
Glenmark Expands Diabetes Care Portfolio with Launch of Empagliflozin and Fixed-Dose Combinations in India
去年
TheracosBio Partners with Publix to Expand Access to Low-Cost SGLT2 Inhibitor BRENZAVVY for Type 2 Diabetes
去年
GLP-1 Agonists Associated with Reduced Blood Clot Risk in Diabetes Patients
去年
Study Reveals Ozempic's Potential as Depression Treatment in Landmark Analysis
第 1 页,共 2 页
上一页
下一页